Roche Acquires Ariosa Diagnostics
With its acquisition of Ariosa Diagnostics, Roche enters the market for noninvasive prenatal testing and cell-free DNA testing services.
Read MorePosted by Steve Halasey | Dec 11, 2014 | Company News, Molecular Diagnostics, Prenatal Testing |
With its acquisition of Ariosa Diagnostics, Roche enters the market for noninvasive prenatal testing and cell-free DNA testing services.
Read MorePosted by Steve Halasey | Dec 9, 2014 | Research |
Clinical study presented at the Society of Urologic Oncology annual meeting validates active surveillance threshold using Prolaris score.
Read MorePosted by Steve Halasey | Nov 25, 2014 | Research |
UCSF researchers identify patterns of genetic activity that could help in early detection of disorder that affects millions of women.
Read MorePosted by Steve Halasey | Nov 25, 2014 | Research |
Massachusetts researchers find panel-based genetic diagnostic testing for inherited eye diseases is highly accurate and more sensitive than exome sequencing.
Read MorePosted by Steve Halasey | Nov 4, 2014 | Uncategorized |
The combination of LabCorp and Covance will create a comprehensive healthcare diagnostics company offering customers end-to-end solutions for drug and diagnostics development and commercialization.
Read More